Liuzhi Zhou

635 total citations
16 papers, 512 citations indexed

About

Liuzhi Zhou is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Liuzhi Zhou has authored 16 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Liuzhi Zhou's work include Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (8 papers) and MicroRNA in disease regulation (3 papers). Liuzhi Zhou is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (8 papers) and MicroRNA in disease regulation (3 papers). Liuzhi Zhou collaborates with scholars based in China and United States. Liuzhi Zhou's co-authors include Yuan Ding, Qianhui Xu, Weilin Wang, Zhongquan Sun, Zongrui Tong, Zhengwei Mao, Sitong Zhang, Yang Bai, Hao Xu and Hao Ding and has published in prestigious journals such as Acta Biomaterialia, BMC Bioinformatics and Advanced Science.

In The Last Decade

Liuzhi Zhou

15 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liuzhi Zhou China 10 236 185 183 133 119 16 512
Yi Cheng China 15 374 1.6× 171 0.9× 298 1.6× 96 0.7× 162 1.4× 30 734
Juanjuan Dang China 8 501 2.1× 204 1.1× 210 1.1× 119 0.9× 142 1.2× 9 657
Yechang Qian China 16 213 0.9× 183 1.0× 171 0.9× 51 0.4× 110 0.9× 28 578
Yawen Ding China 10 328 1.4× 143 0.8× 165 0.9× 132 1.0× 114 1.0× 23 512
Huizi Deng China 8 301 1.3× 135 0.7× 244 1.3× 118 0.9× 94 0.8× 8 568
Xuliang Guo China 12 342 1.4× 178 1.0× 184 1.0× 99 0.7× 178 1.5× 18 640
Xuan Meng China 8 455 1.9× 187 1.0× 186 1.0× 122 0.9× 154 1.3× 17 643
Chenyi Huang China 10 306 1.3× 194 1.0× 137 0.7× 45 0.3× 74 0.6× 12 456

Countries citing papers authored by Liuzhi Zhou

Since Specialization
Citations

This map shows the geographic impact of Liuzhi Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liuzhi Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liuzhi Zhou more than expected).

Fields of papers citing papers by Liuzhi Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liuzhi Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liuzhi Zhou. The network helps show where Liuzhi Zhou may publish in the future.

Co-authorship network of co-authors of Liuzhi Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Liuzhi Zhou. A scholar is included among the top collaborators of Liuzhi Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liuzhi Zhou. Liuzhi Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Huang, Zhaoshuai, et al.. (2023). Inhibition of SK2 and ER stress ameliorated inflammation and apoptosis in liver ischemia-reperfusion injury. Liver Transplantation. 29(10). 1050–1062. 6 indexed citations
3.
Chen, Jiamin, Liming Shao, Lingling Wang, et al.. (2023). Machine Learning-derived Multi-omics Prognostic Signature ofPyroptosis-related lncRNA with Regard to ZKSCAN2-DT and TumorImmune Infiltration in Colorectal Cancer. Combinatorial Chemistry & High Throughput Screening. 27(8). 1161–1174. 3 indexed citations
4.
Li, Hongbo, et al.. (2022). N6-Methyladenosine-Related lncRNAs Are Anticipated Biomarkers for Sarcoma Patients. Journal of Oncology. 2022. 1–10. 4 indexed citations
5.
Gao, Shiqi, Liuzhi Zhou, Jianan Lü, et al.. (2022). Cepharanthine Attenuates Early Brain Injury after Subarachnoid Hemorrhage in Mice via Inhibiting 15‐Lipoxygenase‐1‐Mediated Microglia and Endothelial Cell Ferroptosis. Oxidative Medicine and Cellular Longevity. 2022(1). 4295208–4295208. 64 indexed citations
6.
7.
Ding, Yuan, Sitong Zhang, Zhongquan Sun, et al.. (2022). Preclinical validation of silibinin/albumin nanoparticles as an applicable system against acute liver injury. Acta Biomaterialia. 146. 385–395. 33 indexed citations
8.
Yin, Lu, Liuzhi Zhou, Shiqi Gao, et al.. (2022). Classification of Hepatocellular Carcinoma Based on N6-Methylandenosine–Related lncRNAs Profiling. Frontiers in Molecular Biosciences. 9. 807418–807418. 11 indexed citations
9.
Ding, Yuan, Zhongquan Sun, Sitong Zhang, et al.. (2021). Downregulation of snoRNA SNORA52 and Its Clinical Significance in Hepatocellular Carcinoma. BioMed Research International. 2021(1). 7020637–7020637. 15 indexed citations
10.
Zhang, Boxiang, Rui Wang, Kai Li, et al.. (2021). An Immune-Related lncRNA Expression Profile to Improve Prognosis Prediction for Lung Adenocarcinoma: From Bioinformatics to Clinical Word. Frontiers in Oncology. 11. 671341–671341. 10 indexed citations
11.
Yin, Lu, Liuzhi Zhou, & Rujun Xu. (2021). Identification of Tumor Mutation Burden and Immune Infiltrates in Hepatocellular Carcinoma Based on Multi-Omics Analysis. Frontiers in Molecular Biosciences. 7. 599142–599142. 23 indexed citations
12.
Ding, Yuan, Zhongquan Sun, Zongrui Tong, et al.. (2020). Tumor microenvironment-responsive multifunctional peptide coated ultrasmall gold nanoparticles and their application in cancer radiotherapy. Theranostics. 10(12). 5195–5208. 93 indexed citations
13.
Ding, Yuan, Zhongquan Sun, Sitong Zhang, et al.. (2020). Identification of snoRNA SNORA71A as a Novel Biomarker in Prognosis of Hepatocellular Carcinoma. Disease Markers. 2020. 1–7. 15 indexed citations
14.
Ding, Yuan, Zhongquan Sun, Sitong Zhang, et al.. (2020). Down-regulation of small nuclear RNA (snRNA) RNU5E-1 in hepatocellular carcinoma presents with vital clinical significance. Journal of Gastrointestinal Oncology. 11(4). 738–746. 9 indexed citations
15.
Ding, Yuan, Hao Xu, Chang Xu, et al.. (2020). A Nanomedicine Fabricated from Gold Nanoparticles‐Decorated Metal–Organic Framework for Cascade Chemo/Chemodynamic Cancer Therapy. Advanced Science. 7(17). 2001060–2001060. 207 indexed citations
16.
Ding, Yuan, Zhongquan Sun, Sitong Zhang, et al.. (2020). Revealing the clinical significance and prognostic value of small nucleolar RNA SNORD31 in hepatocellular carcinoma. Bioscience Reports. 40(7). 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yi Cheng Breakdown of academic impact, for papers by Juanjuan Dang Breakdown of academic impact, for papers by Yechang Qian Breakdown of academic impact, for papers by Yawen Ding Breakdown of academic impact, for papers by Huizi Deng Breakdown of academic impact, for papers by Xuliang Guo Breakdown of academic impact, for papers by Xuan Meng Breakdown of academic impact, for papers by Chenyi Huang
Rankless by CCL
2026